Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 162 M166 M178 M169 M129 M180 M 656 M Research & development —————— — Operating income -197 M277 M148 M75 M-279 M-168 M -224 M Non-Operating Income, Total -36 M-39 M-37 M-45 M-38 M-46 M -166 M Interest expense, net of interest capitalized -12 M-9 M-8 M-8 M-10 M-13 M -39 M Non-Operating Income, excl. Interest Expenses -28 M-35 M-31 M-31 M-37 M-39 M -138 M Unusual income/expense -8 M-4 M2 M-6 M9 M6 M 11 M Pretax income -233 M238 M111 M30 M-317 M-214 M -390 M Equity in earnings —————— — Taxes -67 M66 M38 M9 M-124 M-138 M -215 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -166 M172 M73 M21 M-193 M-76 M -175 M Discontinued operations —————— — Net income -166 M172 M73 M21 M-193 M-76 M -175 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -166 M172 M73 M21 M-193 M-76 M -175 M Basic earnings per share (Basic EPS) -1.351.450.630.12-1.69-0.68 -1.62 Diluted earnings per share (Diluted EPS) -1.351.420.620.14-1.69-0.68 -1.61 Average basic shares outstanding 123.13 M118.85 M115.29 M118.17 M114.29 M111.13 M — Diluted shares outstanding 123.13 M120.93 M117.5 M119.93 M114.29 M111.13 M — EBITDA -3 M476 M351 M274 M-75 M39 M 589 M EBIT -197 M277 M148 M75 M-279 M-168 M -224 M Cost of revenue 304 M342 M369 M344 M352 M1.67 B 2.74 B Other cost of goods sold 304 M342 M369 M344 M352 M1.67 B 2.74 B Depreciation & amortization (cash flow) 194 M199 M203 M199 M204 M207 M 813 M